Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001)
Clinical trial NCT01963260 · COMPLETED
Trial details
- NCT number
- NCT01963260
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-31
- Primary completion
- 2015-04-26
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.